Skip to Content
NutrientsNutrients
  • Opinion
  • Open Access

9 April 2018

20 Pages

A Mediterranean Diet Model in Australia: Strategies for Translating the Traditional Mediterranean Diet into a Multicultural Setting

,
,
,
,
and
1
Department of Rehabilitation, Nutrition and Sport, La Trobe University, Health Sciences 3, Kingsbury Drive, Bundoora, VIC 3086, Australia
2
School of Exercise and Nutrition Sciences, Deakin University, Building J, 221 Burwood Hwy, Burwood, VIC 3125, Australia
3
School of Allied Health, University of Limerick, Castletroy, Limerick V94 T9PX, Ireland
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Health Benefits of Mediterranean Diet

Abstract

Substantial evidence supports the effect of the Mediterranean Diet (MD) for managing chronic diseases, although trials have been primarily conducted in Mediterranean populations. The efficacy and feasibility of the Mediterranean dietary pattern for the management of chronic diseases has not been extensively evaluated in non-Mediterranean settings. This paper aims to describe the development of a MD model that complies with principles of the traditional MD applied in a multiethnic context. Optimal macronutrient and food-based composition was defined, and a two-week menu was devised incorporating traditional ingredients with evidence based on improvements in chronic disease management. Strategies were developed for the implementation of the diet model in a multiethnic population. Consistent with the principles of a traditional MD, the MD model was plant-based and high in dietary fat, predominantly monounsaturated fatty acids from extra virgin olive oil. Fruits, vegetables and wholegrains were a mainstay, and moderate amounts of nuts and seeds, fish, dairy and red wine were recommended. The diet encompassed key features of the MD including cuisine, biodiversity and sustainability. The MD model preserved traditional dietary components likely to elicit health benefits for individuals with chronic diseases, even with the adaptation to an Australian multiethnic population.

1. Introduction

There is a substantial body of evidence to support the efficacy of the Mediterranean Diet (MD) in chronic disease prevention and management [1]. In this regard, results from several intervention studies support the efficacy of a MD for individuals with cardiovascular disease (CVD) as well as a broad range of associated disease states, including metabolic syndrome, type 2 diabetes mellitus (T2DM), cognitive function decline, depression and anxiety, autoimmune diseases, cancer and non-alcoholic fatty liver disease (NAFLD) [2,3,4]. As inflammation drives insulin resistance and oxidative stress [5,6], the anti-inflammatory and antioxidant properties of the MD pattern are proposed to slow the progression of some of the oxidative damage associated with the aforementioned clinical conditions [7,8].
Some of the proposed benefits of the MD pertain to the dietary pattern as a whole. This encompasses overall macro and micronutrient composition, the variety of foods included as well as the combination, preparation and consumption of these foods which contribute to the synergistic effect of the food matrix [9]. The combination of foods and how these are traditionally prepared is often referred to as cuisine, and this is a key element of the MD that is likely to contribute to added health benefits [10].
The majority of clinical trials which have assessed the efficacy of the MD have been conducted in Mediterranean populations, where this dietary pattern and these types of foods are familiar [1]. Embedding the principles of a MD in non-Mediterranean populations worldwide with different habitual food cultures remains a great challenge. Australia is a culturally diverse nation, with almost half the population (49%) having either been born overseas or with at least one parent born overseas [11]. Given the high prevalence of chronic disease in Australia, and the scientific evidence base of the MD, assessing the efficacy of the diet for the prevention and management of these diseases in this population group is warranted. However, given the heterogeneity around the definitions and interpretations of what constitutes a MD intervention, researchers need to be transparent about the exact methods and dietary prescriptions used to ensure reproducibility and translation of favourable effects for other research studies and to drive practice change [12].
The current paper provides the rationale and process undertaken for the development of a MD model intervention in two clinical trials, currently underway. Protocols for each study are presented elsewhere Papamiltiadous et al. [13] and Itsiopoulos et al. [14]. In this context, the specific aims of the present study were (1) to identify the nutrient composition profiles of previous MD interventions delivered to Mediterranean and Australian populations; (2) to identify the key dietary and food-based components within the MD (with evidence-based health benefits) and to use these to develop key food intake recommendations; (3) to develop a two-week meal plan based on the nutrient composition profile and the key food intake recommendations identified in the previous steps; and (4) to assess the barriers to translatability of this dietary pattern to multiethnic Australian populations with chronic disease and to develop strategies to overcome these.

2. Methodological Steps to Address Each Specific Aim

A MD intervention for provision in an Australian, multiethnic population with diagnosed NAFLD and CVD, undergoing clinical trial conditions, was developed using the below steps which are summarized in Figure 1.
Figure 1. A schematic summarising the key methodological steps taken to develop a Mediterranean Diet model for an Australian multicultural setting. MD: Mediterranean Diet.

2.1. Step One: Identification of the Nutrient Composition Profile of Previous MD Interventions Delivered to Mediterranean and Australian Populations

In determining the key nutrients required to achieve a MD, it was important to establish a clear definition of a ‘MD pattern’ using a strong evidence base. This included using MD interventions that have successfully translated this dietary pattern and achieved health benefits. There have been a number of trials published, which refer to and apply a MD intervention; however, the nutrient composition across the literature remains inconsistent [12]. Therefore, the authors used the Cretan MD as the definition for this MD model, which was determined using published data from trials based on the archetypal traditional Cretan (Greek) MD [15]. These dietary practices have been the most pivotal in demonstrating prevention and management of chronic disease [16,17,18].
A comprehensive assessment of MD studies, including seminal MD trials in Mediterranean regions and smaller clinical trials implemented in the Australian context, was conducted. Nutrient composition data is depicted in Table 1. From this assessment the nutrient compositions for this intervention were derived and are discussed below.
Table 1. Nutrient data from the seminal Keys study and subsequent clinical trials within Mediterranean regions and clinical trials using a Mediterranean diet in Australian populations.
Table 1 captures the nutrient composition from trials where substantial benefits were demonstrated with the prescription of the MD. Benefits were defined as improvements in outcome measures in a range of chronic diseases or where feasibility in an Australian population was shown.
Of note, the landmark LYON diet heart study was clearly the most impressive secondary prevention trial using a Mediterranean style diet to prevent secondary myocardial infarcts; however, the dietary intervention model of this trial was not used to inform our intervention model due to major differences in fat type. The LYON heart study had a heavy reliance on high alpha-linolenic acid (ALA) canola oil and margarine which are not documented traditional fats used in the MD [22]. Clinical trials encompassing traditional MD principles that have been carried out in non-Mediterranean regions, namely Australia, were feeding trials that provided all meals to participants for the study duration [4,19]. These trials demonstrated ‘proof of concept’ that positive health outcomes can be achieved for chronic disease states in Australian populations with consumption of a MD. Ongoing provision of complete meals is not achievable and is cost prohibitive in clinical trials and does not adequately represent the feasibility of implementing this dietary pattern in a free living population. Therefore, the Australian dietary intervention developed and described herein encompasses the traditional MD patterns for application in free living participants [13].

2.2. Step Two: Identification of the Key Food-Based Components of a MD with Strong Published Evidence of Health Benefits

Using the nutrient profile derived in step one, food components with health promoting effects were used to formulate a meal plan. When translating optimal levels of essential nutrients into food-based recommendations, references in Table 1 were used as a guide, as were the Hellenic dietary guidelines [23]. It is worth noting that since the development of this MD model intervention model, the Hellenic dietary guidelines have been updated. Cross referencing with published MD food group recommendations, labelled ‘commandments’, was also carried out [24]. Determination of key food-based recommendations and a review of the evidence-based mechanisms surrounding these dietary components were conducted; these are summarised in Table 2.
Table 2. Nutrient composition of the Australian Mediterranean Diet *.
For both steps one and two, there was also consideration of other evidence-based, disease specific dietary recommendations. For example, for CVD patients, the National Heart Foundation guidelines were incorporated, and for NAFLD patients, alcohol recommendations were kept to the lower end of the suggested range. This was important to ensure that the MD model dietary model did not was consistent with established clinical guidelines for these medical conditions.

2.3. Step Three: Development of a Two-Week Meal Plan Based on the Nutrient Composition Profile and the Key Food Intake Recommendations Identified in the Previous Steps

Based on steps one and two, a two-week meal plan, suitable for an Australian multiethnic population was developed (Figure S1). The meal plan was based on the macro and micronutrients and food-based components consistent with a traditional MD. These meal plans were analyzed using a standard food analysis program, Foodworks 7™, to ensure nutrient composition was consistent with the desired profile as identified in step one. The two-week meal plan also incorporated other key elements of the MD highlighted in step two, including combinations and preparation of foods described as part of the MD cuisine.

2.4. Step Four: Identification of Potential Barriers and Proposal of Strategies for Translating MD into the Australian Population

The studies presented are summarized in Table 1 and Table 2 and were used to determine the perceived feasibility of the intervention through highlighting potential barriers for the translation of a MD into the Australian population. To overcome these barriers, a theoretical framework encompassing a SWOT (strengths, weaknesses, opportunities, threats) analysis was conducted. This was carried out to identify barriers that were likely to occur and embed strategies within the MD model to overcome these. This SWOT analysis was conducted alongside the experience and expertise of practising dietitians and researchers to ensure appropriate strategies were embedded into the intervention with the aim of addressing the perceived barriers identified.

4. General Overview and Future Implications

This paper described the nutrient and food-based components of a traditional Mediterranean diet using data from seminal trials and a cohort trial including dietary intakes of people from Crete in the 1950s, considered the archetypal traditional Mediterranean diet. This information was used to model the development of a MD model for specific use in two multiethnic cohorts with chronic diseases: CVD [14] and NAFLD [13].
The MD model intervention includes specific dietary prescription, including a breakdown of macro and micronutrients and food components. This allows for transparency when reviewing literature and thus optimal analysis of dietary adherence and translation into other research trials and clinical practice. This belief around ensuring transparency was inherent in the modelling of this paper through the development and design of the MD model intervention and showed that the components of the Mediterranean cuisine [20,30] could be maintained across a number of different cultural cuisines. There is a strong rationale for assessing the efficacy of the MD in a Western, multicultural population where there is a need to identify a superior dietary pattern that can prevent and manage the growing epidemic of chronic diseases. This dietary pattern should also be assessed for its ability to be achieved and sustained by individuals. Furthermore, the MD model described herein has been developed for application within free living populations. This is an important strength of this dietary intervention model because theoretically, if adopted by individuals, it is more likely to be sustained. Sustainability is an outcome that is critical for the management of chronic diseases.
Having comprehensively reviewed the key nutrients, foods and mechanisms which facilitate health benefits, the development of this MD model intervention is anticipated to be comparable to interventions delivered in the Mediterranean basin. The MD model intervention is consistent with the traditional MD, being a predominantly plant-based diet high in dietary fat, predominantly from MUFA from EVOO consumption. The MD model intervention reported in this paper also features moderate amounts of fermented dairy, fish and white meat with minimal amounts of red meat. White and red meat portions are higher than those consumed as part of a traditional MD, where an allowance of 450 g/week was developed in accordance with successful clinical trials described in Table 1 and Table 2. This resulted in a slightly higher total protein recommendation in the MD model (Table 3) compared with percentages reported in the traditional MD counterpart. Furthermore, there is an increased amount of prescribed α-linoleic acid and total long chain n-3s included within the MD model intervention model in an effort to improve the n6:n3 ratio consumed, which is indicated in clinical practice guidelines for CVD.
This intervention is in line with the whole diet approach for MD, which has been shown to be more healthful compared to isolated nutrients [9]. As well as a whole of diet approach, the inclusion of cuisine means that the MD model intervention incorporates a combination of foods and optimises health outcomes based on the enhanced benefits of the food matrix and the preparation of these combinations.
Incorporating elements of cuisine such as combining EVOO with herbs and tomatoes resulted in the improved bioavailability of antioxidants and micronutrients; however, preparation may be considered challenging or not suitable for individuals who seek or require convenient options. To overcome this potential barrier the MD model intervention includes a range of non-cooking meal options for participants to ensure convenience, optimise consistency amongst dietary adherence and to enable sustainability. To date we are not aware of any direct comparison surrounding the effects of cuisine in cooked and raw meals. It is also likely that given the complexity around food and its constituents, results would be variable across specific foods and antioxidants.
One of the other key predicted barriers with application of a MD in non-Mediterranean countries, such as Australia, is the adaptability to other cultural preferences. This has been highlighted as a perceived barrier in other countries who have considered the application of a MD for the prevention and management of chronic diseases [75]. This paper showcased some practical solutions surrounding how to apply MD principles within other cultural dishes. In particular, the demonstration of the commonalities between ingredients and combinations from traditional dishes from range of countries was presented and how the composition and cuisine could be optimised with only minor recipe changes.

5. Conclusions

The MD model intervention maintained traditional dietary components to ensure that reported health benefits could be preserved while the context was adapted and evolved to suit an Australian multiethnic population. There were multiple factors that were considered, and thus, steps were developed to include strong evidence base and strategies surrounding potential barriers were applied to achieve this. Firstly, an optimal evidence-based dietary prescription which encompassed nutrition composition, ingredients and food combinations which were likely to elicit health benefits was adopted. Next, the dietary prescriptions were designed in a way that could be implemented across multiple cultures. This MD model is currently being assessed for acceptability and feasibility for participants with chronic diseases in two clinical trials. This MD model intervention demonstrates that it is possible to translate the key elements of the traditional MD to populations outside the Mediterranean region to increase the likelihood of acceptability and sustainability. Furthermore, this paper indicates the need for a consistent definition to describe the MD to ensure the key elements are captured and translated so that the translated MD model retains authenticity. The MD model and accompanying resources described herein can be used by nutrition researchers for future clinical trials adopting a MD. In addition, they may be used by health practitioners in the care of their patients with chronic diseases and by policy makers to provide evidence-based food guidelines for the prevention and management of many chronic diseases.

Supplementary Materials

The following are available online at http://www.mdpi.com/2072-6643/10/4/465/s1, Figure S1: Mediterranean Diet: two week cycle menu, Figure S2: Mediterranean Dietary Guidelines- Summary, Figure S3: Mediterranean Diet Pyramid, Figure S4: “No Cooking” Meal Options, Figure S5: Shopping List.

Acknowledgments

This work was supported by an Australian Government Research Training Program Scholarship (ESG).

Author Contributions

E.S.G. and T.K. designed the dietary intervention and resources with the support of A.C.T. and C.I., E.S.G. and H.L.M. delivered the dietary intervention and application of the intervention design. E.S.G. drafted the manuscript. All authors contributed to the critical review and approval of the final manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sofi, F.; Macchi, C.; Abbate, R.; Gensini, G.F.; Casini, A. Mediterranean diet and health status: An updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr. 2014, 17, 2769–2782. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  2. Sofi, F.; Abbate, R.; Gensini, G.F.; Casini, A. Accruing evidence on benefits of adherence to the mediterranean diet on health: An updated systematic review and meta-analysis. Am. J. Clin. Nutr. 2010, 92, 1189–1196. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  3. Itsiopoulos, C.; Hodge, A.; Kaimakamis, M. Can the mediterranean diet prevent prostate cancer? Mol. Nutr. Food Res. 2009, 53, 227–239. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  4. Ryan, M.C.; Itsiopoulos, C.; Thodis, T.; Ward, G.; Trost, N.; Hofferberth, S.; O’Dea, K.; Desmond, P.V.; Johnson, N.A.; Wilson, A.M. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J. Hepatol. 2013, 59, 138–143. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  5. Dhalla, N.S.; Temsah, R.M.; Netticadan, T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 2000, 18, 655–673. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  6. Khansari, N.; Shakiba, Y.; Mahmoudi, M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat. Inflamm. Allergy Drug Discov. 2009, 3, 73–80. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  7. Esposito, K.; Marfella, R.; Ciotola, M.; Di Palo, C.; Giugliano, F.; Giugliano, G.; D’Armiento, M.; D’Andrea, F.; Giugliano, D. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA 2004, 292, 1440–1446. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  8. Estruch, R. Anti-inflammatory effects of the Mediterranean diet: The experience of the PREDIMED study. Proc. Nutr. Soc. 2010, 69, 333–340. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  9. Widmer, R.J.; Flammer, A.J.; Lerman, L.O.; Lerman, A. The mediterranean diet, its components, and cardiovascular disease. Am. J. Med. 2015, 128, 229–238. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  10. Fielding, J.M.; Rowley, K.G.; Cooper, P.; O’Dea, K. Increases in plasma lycopene concentration after consumption of tomatoes cooked with olive oil. Asia Pac. J. Clin. Nutr. 2005, 14, 131–136. [Google Scholar] [PubMed]
  11. Australian Bureau of Statistics. Census Reveals a Fast Changing, Culturally Diverse Nation; Australian Government: Canberra, Australia, 2017.
  12. Dinu, M.; Pagliai, G.; Casini, A.; Sofi, F. Mediterranean diet and multiple health outcomes: An umbrella review of meta-analyses of observational studies and randomised trials. Eur. J. Clin. Nutr. 2018, 72, 30–43. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  13. Papamiltiadous, E.S.; Roberts, S.K.; Nicoll, A.J.; Ryan, M.C.; Itsiopoulos, C.; Salim, A.; Tierney, A.C. A randomised controlled trial of a Mediterranean dietary intervention for adults with non alcoholic fatty liver disease (MEDINA): Study protocol. BMC Gastroenterol. 2016, 16, 14. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  14. Itsiopoulos, C.; Kucianski, T.; Mayr, H.L.; van Gaal, W.J.; Martinez-Gonzalez, M.; Vally, H. The AUStralian MEDiterranean Diet Heart Trial (AUSMED Heart Trial): A randomised clinical trial in secondary prevention of coronary heart disease in a multi-ethnic Australian population: Study Protocol. Am. Heart J. 2018. under review. [Google Scholar]
  15. Keys, A.; Mienotti, A.; Karvonen, M.J.; Aravanis, C.; Blackburn, H.; Buzina, R.; Djordjevic, B.; Dontas, A.; Fidanza, F.; Keys, M.H.; et al. The diet and 15-year death rate in the seven countries study. Am. J. Epidemiol. 1986, 124, 903–915. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  16. Keys, A.; Menotti, A.; Aravanis, C.; Blackburn, H.; Djordevič, B.S.; Buzina, R.; Dontas, A.S.; Fidanza, F.; Karvonen, M.J.; Kimura, N.; et al. The seven countries study: 2,289 deaths in 15 years. Prev. Med. 1984, 13, 141–154. [Google Scholar] [CrossRef] [Scilit]
  17. Trichopoulou, A.; Vasilopoulou, E.; Lagiou, A. Mediterranean diet and coronary heart disease: Are antioxidants critical? Nutr. Rev. 1999, 57, 253–255. [Google Scholar] [PubMed]
  18. Trichopoulou, A.; Lagiou, P. Healthy traditional mediterranean diet: An expression of culture, history, and lifestyle. Nutr. Rev. 1997, 55, 383–389. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  19. Itsiopoulos, C.; Brazionis, L.; Kaimakamis, M.; Cameron, M.; Best, J.D.; O’Dea, K.; Rowley, K. Can the mediterranean diet lower HbA1c in type 2 diabetes? Results from a randomized cross-over study. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 740–747. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  20. Estruch, R.; Ros, E.; Salas-Salvadó, J.; Covas, M.-I.; Corella, D.; Arós, F.; Gómez-Gracia, E.; Ruiz-Gutiérrez, V.; Fiol, M.; Lapetra, J.; et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 2013, 368, 1279–1290. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  21. Vincent-Baudry, S.; Defoort, C.; Gerber, M.; Bernard, M.C.; Verger, P.; Helal, O.; Portugal, H.; Planells, R.; Grolier, P.; Amiot-Carlin, M.J.; et al. The MEDI-RIVAGE study: Reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet. Am. J. Clin. Nutr. 2005, 82, 964–971. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  22. Leaf, A. Dietary prevention of coronary heart disease: The lyon diet heart study. Circulation 1999, 99, 733–735. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  23. Ministry of Health and Welfare. Dietary Guidelines for Adults in Greece. Arch. Hell. Med. 1999, 16, 516–524. [Google Scholar]
  24. Itsiopoulos, C. The Mediterranean Diet; Macmillan Publishers: Melbourne, Australia, 2013. [Google Scholar]
  25. National Health and Medical Research Council. Australian Guidelines to Reduce Health Risks from Drinking Alcohol. Available online: https://www.nhmrc.gov.au/health-topics/alcohol-guidelines (accessed on 25 May 2016).
  26. Meschino, J.P. How components of the Mediterranean diet reduce heart disease and stroke risk. Dyn. Chiropr. 2013, 31, 8. [Google Scholar]
  27. Ross, S.M. Effects of extra virgin olive oil phenolic compounds and the Mediterranean diet on cardiovascular health. Holist. Nurs. Pract. 2013, 27, 303–307. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  28. Simopoulos, A.P.; Sidossis, L. What is so special about the traditional diet of Greece. World Rev. Nutr. Diet. 2000, 87, 24–42. [Google Scholar] [PubMed]
  29. Simopoulos, A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother. 2002, 56, 365–379. [Google Scholar] [CrossRef] [Scilit]
  30. Bach-Faig, A.; Berry, E.M.; Lairon, D.; Reguant, J.; Trichopoulou, A.; Dernini, S.; Medina, F.X.; Battino, M.; Belahsen, R.; Miranda, G.; et al. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 2011, 14, 2274–2284. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  31. McNaughton, S.A.; Ball, K.; Crawford, D.; Mishra, G.D. An index of diet and eating patterns is a valid measure of diet quality in an Australian population. J. Nutr. 2008, 138, 86–93. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  32. Aroney, C.; Aylward, P.; Kelly, A.; Chew, D.; Clune, E. National Heart Foundation of Australia Cardiac Society of Australia and New Zealand guidelines for the management of acute coronary syndromes 2006. Med. J. Aust. 2006, 184, S1–S32. [Google Scholar]
  33. Wang, C.H.; Wey, K.C.; Mo, L.R.; Chang, K.K.; Lin, R.C.; Kuo, J.J. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma. Asian Pac. J Cancer Prev. 2015, 16, 3595–3604. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  34. Psaltopoulou, T.; Naska, A.; Orfanos, P.; Trichopoulos, D.; Mountokalakis, T.; Trichopoulou, A. Olive oil, the Mediterranean diet, and arterial blood pressure: The Greek European prospective investigation into cancer and nutrition (EPIC) study. Am. J. Clin. Nutr. 2004, 80, 1012–1018. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  35. Lamuela-Raventós, R.M.; Gimeno, E.; Fito, M.; Castellote, A.-I.; Covas, M.; de la torre-boronat, M.C.; López-Sabater, M.C. Interaction of olive oil phenol antioxidant components with low-density lipoprotein. Biol. Res. 2004, 37, 247–252. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  36. Stark, A.H.; Madar, Z. Olive oil as a functional food: Epidemiology and nutritional approaches. Nutr. Rev. 2002, 60, 170–176. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  37. Kinoshita, T.; Lepp, Z.; Chuman, H. Approach to novel functional foods for stress control 1. Toward structure-activity relationship and data mining of food compounds by chemoinformatics. J. Med. Investig. 2005, 52, 240–241. [Google Scholar] [CrossRef] [Scilit]
  38. Kushi, L.H.; Lenart, E.B.; Willett, W.C. Health implications of mediterranean diets in light of contemporary knowledge. 1. Plant foods and dairy products. Am. J. Clin. Nutr. 1995, 61, 1407S–1415S. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  39. Ortega, R.M.; Palencia, A.; López-Sobaler, A.M. Improvement of cholesterol levels and reduction of cardiovascular risk via the consumption of phytosterols. Br. J. Nutr. 2006, 96, S89–S93. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  40. Serra Majem, L.; García Alvarez, A.; Ngo de la Cruz, J. Dieta Mediterránea: Características y beneficios para la salud. Arch. Latinoam. Nutr. 2004, 54, 44–51. [Google Scholar] [PubMed]
  41. Kouris-Blazos, A.; Belski, R. Health benefits of legumes and pulses with a focus on Australian sweet lupins. Asia Pac. J. Clin. Nutr. 2016, 25, 1–17. [Google Scholar] [PubMed]
  42. Darmadi-Blackberry, I.; Wahlqvist, M.L.; Kouris-Blazos, A.; Steen, B.; Lukito, W.; Horie, Y.; Horie, K. Legumes: The most important dietary predictor of survival in older people of different ethnicities. Asia Pac. J. Clin. Nutr. 2004, 13, 217–220. [Google Scholar] [PubMed]
  43. Samman, S.; Sivarajah, G.; Man, J.C.; Ahmad, Z.I.; Petocz, P.; Caterson, I.D. A mixed fruit and vegetable concentrate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men. J. Nutr. 2003, 133, 2188–2193. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  44. Bazzano, L.A.; He, J.; Ogden, L.G.; Loria, C.; Vupputuri, S.; Myers, L.; Whelton, P.K. Legume consumption and risk of coronary heart disease in US men and women: NHANES I epidemiologic follow-up study. Arch. Intern. Med. 2001, 161, 2573–2578. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  45. Becerra-Tomás, N.; Díaz-López, A.; Rosique-Esteban, N.; Ros, E.; Buil-Cosiales, P.; Corella, D.; Estruch, R.; Fitó, M.; Serra-Majem, L.; Arós, F.; et al. Legume consumption is inversely associated with type 2 diabetes incidence in adults: A prospective assessment from the PREDIMED study. Clin. Nutr. 2017. [Google Scholar] [CrossRef] [Scilit]
  46. Ruxton, C.; Reed, S.C.; Simpson, M.; Millington, K. The health benefits of omega-3 polyunsaturated fatty acids: A review of the evidence. J. Hum. Nutr. Diet. 2004, 17, 449–459. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  47. Biesalski, H.-K. Meat as a component of a healthy diet—Are there any risks or benefits if meat is avoided in the diet? Meat Sci. 2005, 70, 509–524. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  48. Sinha, R.; Cross, A.J.; Graubard, B.I.; Leitzmann, M.F.; Schatzkin, A. Meat intake and mortality: A prospective study of over half a million people. Arch. Intern. Med. 2009, 169, 562–571. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  49. John, J.; Ziebland, S.; Yudkin, P.; Roe, L.; Neil, H. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: A randomised controlled trial. Lancet 2002, 359, 1969–1974. [Google Scholar] [CrossRef] [Scilit]
  50. Blomhoff, R.; Carlsen, M.H.; Andersen, L.F.; Jacobs, D.R. Health benefits of nuts: Potential role of antioxidants. Br. J. Nutr. 2006, 96, S52–S60. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  51. Sabaté, J.; Ang, Y. Nuts and health outcomes: New epidemiologic evidence. Am. J. Clin. Nutr. 2009, 89, 1643S–1648S. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  52. Panesar, P.S. Fermented dairy products: Starter cultures and potential nutritional benefits. Food Nutr. Sci. 2011, 2, 47–51. [Google Scholar] [CrossRef]
  53. Ebringer, L.; Ferenčík, M.; Krajčovič, J. Beneficial health effects of milk and fermented dairy products—Review. Folia Microbiol. 2008, 53, 378–394. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  54. Bartram, H.-P.; Scheppach, W.; Gerlach, S.; Ruckdeschel, G.; Kelber, E.; Kasper, H. Does yogurt enriched with bifidobacterium longum affect colonic microbiology and fecal metabolites in health subjects? Am. J. Clin. Nutr. 1994, 59, 428–432. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  55. Slavin, J.L.; Jacobs, D.; Marquart, L.; Wiemer, K. The role of whole grains in disease prevention. J. Am. Diet. Assoc. 2001, 101, 780–785. [Google Scholar] [CrossRef] [Scilit]
  56. Slavin, J. Whole grains and human health. Nutr. Res. Rev. 2004, 17, 99–110. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  57. Slavin, J.L.; Martini, M.C.; Jacobs, D.R.; Marquart, L. Plausible mechanisms for the protectiveness of whole grains. Am. J. Clin. Nutr. 1999, 70, 459s–463s. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  58. Cook, S.I.; Sellin, J.H. Review article: Short chain fatty acids in health and disease. Aliment. Pharmacol. Ther. 1998, 12, 499–507. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  59. Goran, M.I.; Walker, R.; Allayee, H. Genetic-related and carbohydrate-related factors affecting liver fat accumulation. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 392–396. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  60. Jin, R.; Welsh, J.A.; Le, N.-A.; Holzberg, J.; Sharma, P.; Martin, D.R.; Vos, M.B. Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients 2014, 6, 3187–3201. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  61. Handelman, G.J.; Nightingale, Z.D.; Lichtenstein, A.H.; Schaefer, E.J.; Blumberg, J.B. Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolk. Am. J. Clin. Nutr. 1999, 70, 247–251. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  62. Anderson, K.E. Comparison of fatty acid, cholesterol, and vitamin a and e composition in eggs from hens housed in conventional cage and range production facilities. Poult. Sci. 2011, 90, 1600–1608. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  63. Wallerath, T.; Deckert, G.; Ternes, T.; Anderson, H.; Li, H.; Witte, K.; Förstermann, U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002, 106, 1652–1658. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  64. Echeverry, C.; Blasina, F.; Arredondo, F.; Ferreira, M.; Abin-Carriquiry, J.A.; Vasquez, L.; Aspillaga, A.A.; Diez, M.S.; Leighton, F.; Dajas, F. Cytoprotection by neutral fraction of tannat red wine against oxidative stress-induced cell death. J. Agric. Food chem. 2004, 52, 7395–7399. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  65. Ortega, R. Importance of functional foods in the mediterranean diet. Public Health Nutr. 2006, 9, 1136–1140. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  66. Ninfali, P.; Mea, G.; Giorgini, S.; Rocchi, M.; Bacchiocca, M. Antioxidant capacity of vegetables, spices and dressings relevant to nutrition. Br. J. Nutr. 2005, 93, 257–266. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  67. Bower, A.; Marquez, S.; de Mejia, E.G. The health benefits of selected culinary herbs and spices found in the traditional Mediterranean diet. Crit. Rev. Food Sci. Nutr. 2016, 56, 2728–2746. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  68. Stahl, W. Carrots, tomatoes and cocoa: Research on dietary antioxidants in dusseldorf. Arch. Biochem. Biophys. 2016, 595, 125–131. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  69. Wolfson, J.A.; Bleich, S.N. Is cooking at home associated with better diet quality or weight-loss intention? Public Health Nutr. 2015, 18, 1397–1406. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  70. Garcia, A.L.; Reardon, R.; McDonald, M.; Vargas-Garcia, E.J. Community interventions to improve cooking skills and their effects on confidence and eating behaviour. Curr. Nutr. Rep. 2016, 5, 315–322. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  71. Hoffman, R.; Gerber, M. Evaluating and adapting the mediterranean diet for non-mediterranean populations: A critical appraisal. Nutr. Rev. 2013, 71, 573–584. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  72. Radd-Vagenas, S.; Kouris-Blazos, A.; Singh, M.F.; Flood, V.M. Evolution of mediterranean diets and cuisine: Concepts and definitions. Asia Pac. J. Clin. Nutr. 2013, 1–32. [Google Scholar] [CrossRef] [Scilit]
  73. Jordan, C.H.; Wang, W.; Donatoni, L.; Meier, B.P. Mindful eating: Trait and state mindfulness predict healthier eating behavior. Pers. Indiv. Differ. 2014, 68, 107–111. [Google Scholar] [CrossRef] [Scilit]
  74. Burlingame, B.; Dernini, S. Sustainable diets: The mediterranean diet as an example. Public Health Nutr. 2011, 14, 2285–2287. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  75. Moore, S.; McEvoy, C.; Prior, L.; Lawton, J.; Patterson, C.; Kee, F.; Cupples, M.; Young, I.; Appleton, K.; McKinley, M.; et al. Barriers to adopting a mediterranean diet in northern European adults at high risk of developing cardiovascular disease. J. Hum. Nutr. Diet. 2017. [Google Scholar] [CrossRef] [Scilit] [PubMed]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.